S 830referred119th Congress

Lifespan Respite Care Reauthorization Act of 2025

Introduced Mar 4, 2025Senate billPolicy area: HealthLast action Mar 4, 2025Sponsor: Susan M. Collins(R-ME)

healthcareHealth

Health, Education, Labor, and Pensions Committee

Ask about this Build timeline Compare Export source pack

Official Congress record Open in Network Lab Trace connections

Lobbying Filings

$1019.4M

Total Lobbying Spend

Suspicious Trades

Members Involved

Timeline

Jan 24, 2025trade

Gilbert Ray Cisneros, Jr. bought K

Mar 4, 2025bill

Bill introduced

Apr 8, 2025trade

Robert P. Bresnahan, Jr. bought K

Apr 18, 2025lobbying

Lobbying filed by AARP

Apr 21, 2025lobbying

Lobbying filed by ALZHEIMER'S ASSOCIATION

Apr 23, 2025lobbying

Lobbying filed by AMERICAN ACADEMY OF PEDIATRICS

Official Congressional Actions

Mar 4, 2025IntroReferral

Introduced in Senate

View official action

Mar 4, 2025IntroReferral

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1498)

Health, Education, Labor, and Pensions Committee

View official action

Lobbying Activity

Registrant	Client	Amount	Filed	Period	Issues
AARP	AARP	$663.0M	Apr 18, 2025	2025Q1	HCRMMMAGR
ALZHEIMER'S ASSOCIATION	ALZHEIMER'S ASSOCIATION	$179.0M	Jul 21, 2025	2025Q2	HCRBUD
ALZHEIMER'S ASSOCIATION	ALZHEIMER'S ASSOCIATION

Suspicious Trading Activity

Congress members who traded stocks in companies connected to lobbying on this bill, within 90 days of its introduction date.

Member	Party	Ticker	Company	Trade	Date	Amount	Timing	Lobbying Client	Conflict
Robert P. Bresnahan, Jr.	R	K	K	Buy	Apr 8, 2025	$1,001 - $15,000	35d after	AUTISM SPEAKS	37%
Gilbert Ray Cisneros, Jr.	D	K

Conflict Summary

3 trades by 2 members of Congress in companies connected to lobbying on S 830. The average conflict score is 35%.

Robert P. Bresnahan, Jr. (1 trade)Gilbert Ray Cisneros, Jr. (2 trades)

Methodology: Bill-Lobbying-Trade Connection

CapitolExposed identifies the "bill-lobbying-trade pipeline" by: (1) finding lobbying filings (LD-2) that specifically mention this bill, (2) matching lobbying clients to publicly traded companies, and (3) finding stock trades by members of Congress in those companies within 90 days of the bill's introduction date. Trades made before the bill was introduced are highlighted in red, as they may indicate advance knowledge. This analysis surfaces correlations worthy of scrutiny; it does not prove wrongdoing.